China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 2.3% in First Half of 2023

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 785.2 million yuan in the first half of 2023, up 2.3% year-on-year.

Meanwhile, the company posted 5.2 billion yuan in revenue, up 6.6% year-on-year.

At the end of the reporting period, it had 15.1 billion yuan in total assets and 3.9 billion yuan in total liabilities, with a liability-to-asset ratio of 25.7%.